Altria Group, Inc.
MONYSECigarettesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 15/304% above fair value
$77.17−0.86 (-1.10%)
Close on Nov 2, 2026Market cap $128.85BP/E 15.9Yield 5.39%
Altria Oral Tobacco Products by Quarter
Oral Tobacco Products — Excise Taxes on Products Sold ($M) ($M)
Altria Oral Tobacco Products: $21M in Q3 2026, down 12.5% from a year earlier. That is the lowest of the 42 quarters on record here.
Latest, Q3 2026
21
Period ended Sep 30, 2026
Change on a year earlier
-12.5%
24 in Q3 2025
History
42 quarters
Since Q4 2014
Sources
38
Documents cited below
Where the Q3 2026 figure comes from
“|| Excise taxes | (21) | (24) | (66) | (74)”
Source: Altria Earnings Release (Form 8-K Item 2.02 EX-99.1) (0000764180-26-000112), filed 2026-10-29 ↗
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Altria Oral Tobacco Products ($M), quarterly Q4 2014–Q3 2026 [Data set]. Compiled from Altria SEC filings and investor materials. https://stockdatahq.com/stocks/mo/kpis/oral-excise-tax
See every metric in the Altria KPI table. Data updated Nov 2, 2026.